Amlodipine-induced reversible gum hypertrophy
Gingival hypertrophy is a common manifestation of any pathology affecting gingival and periodontal regions. It commonly follows inflammatory disorders, Vitamin C deficiency, leukemia and due to drugs such as anticonvulsants, immunosuppressants, and calcium channel blockers. Amlodipine is a third gen...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Archives of Global Professionals
2016-01-01
|
| Series: | Archives of Pharmacy Practice |
| Subjects: | |
| Online Access: | http://www.archivepp.com/article.asp?issn=2045-080X;year=2016;volume=7;issue=3;spage=103;epage=105;aulast=Manish |
| Summary: | Gingival hypertrophy is a common manifestation of any pathology affecting gingival and periodontal regions. It commonly follows inflammatory disorders, Vitamin C deficiency, leukemia and due to drugs such as anticonvulsants, immunosuppressants, and calcium channel blockers. Amlodipine is a third generation dihydropyridine derived calcium channel blocker commonly used to treat hypertension. Here, we describe the case of a 45-year-old hypertensive woman who was on amlodipine for 1 year and subsequently developed one of its rarest adverse effects, i.e., gingival hypertrophy. |
|---|---|
| ISSN: | 2045-080X |